Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Clinical trial NCT06540963 · RECRUITING
Trial details
- NCT number
- NCT06540963
- Sponsor
- Giselle Sholler
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2030-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.